Cargando…
Long noncoding RNAs in gastric cancer: functions and clinical applications
Over the last two decades, genome-wide studies have revealed that only a small fraction of the human genome encodes proteins; long noncoding RNAs (lncRNAs) account for 98% of the total genome. These RNA molecules, which are >200 nt in length, play important roles in diverse biological processes,...
Autores principales: | Wang, Jiajun, Sun, Jingxu, Wang, Jun, Song, Yongxi, Gao, Peng, Shi, Jinxin, Chen, Ping, Wang, Zhenning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755433/ https://www.ncbi.nlm.nih.gov/pubmed/26929639 http://dx.doi.org/10.2147/OTT.S95412 |
Ejemplares similares
-
Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer
por: Ma, Bin, et al.
Publicado: (2016) -
MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer
por: Shi, Jinxin, et al.
Publicado: (2021) -
A panel consisting of three novel circulating lncRNAs, is it a predictive tool for gastric cancer?
por: Liu, Jingjing, et al.
Publicado: (2018) -
Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-free Global Proteome Analysis
por: Song, Yongxi, et al.
Publicado: (2020) -
The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta‐analysis
por: Zhong, Xi, et al.
Publicado: (2018)